Portfolio Companies 2026 for Boxer Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Boxer Capital accounts for 21 tracked companies with verified cap-table data, 21 of which disclose round sizes totalling $5.1B. The median disclosed raise is $205M, and the largest is Point Biopharma at $650M, ahead of Mirador Therapeutics ($650M) and Spyre Therapeutics ($644M).
The names that recur most often on these portfolio cap tables are Boxer Capital (21 companies), RA Capital Management (8 companies), Invus (6 companies), Janus Henderson Investors (6 companies), Logos Capital (5 companies), Nextech Invest (5 companies). By latest disclosed round, the market skews Series C (8), Series B (4), Series D (3), Series A (3).
Companies tracked: 21
Disclosed funding total: $5.1B across 21 companies
Median disclosed raise: $205M
Largest raise: Point Biopharma — $650M
Stage mix: Series C 8 · Series B 4 · Series D 3 · Series A 3
